chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient is a 52 y.o. male patient with history of IDDM2, alcohol abuse, GERD, hyperlipidemia who presented to the Hospital with abdominal pain, nausea and vomiting.   Acute pancreatitis, alcohol induced Nausea and vomiting  Alcoholic hepatitis Presented with epigastric / RUQ abdominal pain, nausea vomiting,  ongoing alcohol use ALT 153, AST 280, alk phos 155 on admission with mildly elevated lipase to 108 Abdominal US? coarse increased echogenicity of the liver possibly lobulated contour posteriorly, perihepatic free fluid posteriorly CT abdomen?mild peripancreatic fat stranding around the pancreatic head/uncinate process; hepatic steatosis No indication for steroids for alcoholic hepatitis LFTs improving, repeat in one week   Acute respiratory failure with hypoxia Abnormal CXR Fevers New fevers with O2 sats intermittently around 90% with intermittent cough CXR with low lung volumes with central bronchovascular crowding and mild nonspecific streaky bilateral basilar opacity possibly atelectasis/scarring; infiltrate technically not excluded COVID-19 positive on 3/14, tested given new fever Mildly elevated procal with leukocytosis and significantly elevated CRP Blood cultures without growth Urinary antigens negative CTPA without PE, showed streaky left lower lobe airspace opacity Treating with course of antibiotics for potential bacterial pneumonia and treated with steroids while admitted for COVID   COVID-19 virus infection Date of onset of symptoms: unclear Symptoms present on admission: nausea/vomiting, intermittent cough Date of covid positive test: 3/14 Vaccination status: vaccinated without booster Imaging: CXR as above with streaky bibasilar opacities Oxygen requirements on admission: none Current oxygen requirements: none, though O2 sats at 90% intermittently early in oxygen, did not require oxygen Medical therapy: steroids for short course Significantly elevated CRP Acute toxic/metabolic encephalopathy In setting alcohol withdrawal delirium Delirium for a few days initially, then improved back to baseline Completed taper for alcohol withdrawal   Alcohol use disorder, severe dependence Acute intoxication with withdrawal and delirium Currently enrolled in program Increased daily use after death of wife several months ago secondary to cancer Endorses history of withdrawal/tremors, denies seizures/DTs Agitated initially on admission therefore started on precedex with front load CIWA, triggering frequently Changed to fixed dose lorazepam taper with PRNs with precedex with improvement and completed taper with significant improvement Alcohol cessation recommended   Lactic acidosis LA 2.9 on admission in setting of dehydration and intoxication Elevated up to 3.6 with dehydration and poor hepatic clearance with liver disease Blood cultures negative Resolved   IDDM2 with hyperglycemia Hgb A1c of 7.6% Home regimen metformin, Lantus 18 units nightly However has not used insulin in months Hyperglycemic here with steroids Resume home regimen on discharge   Tobacco use Marijuana use 20 cigarettes/day Occasional marijuana, denies other drug use Cessation recommended   HLD Home atorvastatin held during admission, can resume on discharge
severe headache; Nausea; tired; This is a spontaneous report received from a contactable consumer (reporting on herself). A 72-years-old Non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Lot Number and Expiration Date was not reported), via an unspecified route of administration in Arm Left on 25Feb2021 13:00, as 2nd dose, single dose for covid-19 immunisation. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Lot Number and Expiration Date was not reported), via an unspecified route of administration in Arm Left on 04Feb2021 12:00, as 1st dose, single dose for covid-19 immunisation. Medical history included known allergies: Sulfa, Macrodantin, morphine. The patient received unspecified  medication in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. On 02Mar2021, day 5 woke with severe headache and nausea very tired. Patient did not received any treatment for adverse events. The outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
extremely sick headaches shaking chills the next day... then  once my period started it made my mood and hormones out of control its effected my bi-polar severely the medicines that have always stabilized me are not working   I had covid back in January and the adverse effects have been 1,000 times worse then having a pretty bad case of covid. My mental health has totally gone out of control
This pt received vax on 11/05/99. On 02/08/00 she experienced chickenpox with "many more lesions" than another pt having the same experience.
Initial case received from healthcare professional on 04 February 2012. A 59-year-old male patient, who weighed 92 kilograms, received an infiltration of 2 puncture wounds on his hand and the remainder of the 1858 units in an intramuscular injection (site not reported) of Imogam Rabies-H7, sanofi pasteur SA, (lot number not reported, on 30 January 2012 (also reported as 20 January 2012). The patient also received an intramuscular injection (site not reported) of IMOVAX Rabies, sanofi pasteur SA, (lot number not reported, on 30 January 2012 (also reported as January 2012). On 30 January 2012, the patient was reaching under his truck to pick up garbage and a raccoon came out and bit him on the hand. The patient was given vaccines as post exposure immunizations. The patient's medical history was not reported. The patient took no concomitant medications and had no illnesses at the time of vaccination. The patient had no known allergies. The patient returned to the Emergency Room (ER) reported as on 04 August 2012 (1 day late for dose 2); and reported that on the night of vaccines, he had red blanching in both hands and also had diffuse joint pain. The physician reported it looked like serum sickness. The outcome was reported as not recovered. Documents held by sender: none.
Rash started about 10 days ago.  It started a few days before she had her second but after first Covid vaccine.  After second vaccination the rash got worse.  This consists of reddish papules scattered mostly on her abdomen but a few on her back and a moderate number on her legs.  She had a fever the night she got the second shot and felt really tired but the next day she felt better.  No runny nose, sore throat, earache, sore throat swelling.  She has a cough primarily at night.  She also has pain in the left upper back.  This is not new.  No new medications, supplements, creams, lotions, detergents.
Felt hot in back of his head; Developed a red rash around and behind his head and hairline/Developed a red rash under his arm pit/Developed a red rash in his pelvic area; His hands also itch/He has moments of itchiness throughout his body which comes and goes.; Felt fatigued; Had a strong headache the whole day; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt hot in back of his head), RASH ERYTHEMATOUS (Developed a red rash around and behind his head and hairline/Developed a red rash under his arm pit/Developed a red rash in his pelvic area), PRURITUS (His hands also itch/He has moments of itchiness throughout his body which comes and goes.), FATIGUE (Felt fatigued) and HEADACHE (Had a strong headache the whole day) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939905) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Nov-2021, the patient experienced FATIGUE (Felt fatigued) and HEADACHE (Had a strong headache the whole day). On 08-Nov-2021, the patient experienced FEELING HOT (Felt hot in back of his head), RASH ERYTHEMATOUS (Developed a red rash around and behind his head and hairline/Developed a red rash under his arm pit/Developed a red rash in his pelvic area) and PRURITUS (His hands also itch/He has moments of itchiness throughout his body which comes and goes.). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING HOT (Felt hot in back of his head), RASH ERYTHEMATOUS (Developed a red rash around and behind his head and hairline/Developed a red rash under his arm pit/Developed a red rash in his pelvic area), PRURITUS (His hands also itch/He has moments of itchiness throughout his body which comes and goes.), FATIGUE (Felt fatigued) and HEADACHE (Had a strong headache the whole day) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were included Antihistamine, Benadryl.  No concomitant medications were provided.
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness/Lightheadedness-Mild, Systemic: Exhaustion/Lethargy-Medium, Systemic: Flushed/Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Mild, Additional Details: Difficulty lifting arm the morning after immunization. Shortness of breath during walk in the park. Unable to do walk as usual.
Low-grade fever, chills, body aches, headache all presented abruptly 12 hours after the injection. Fever, chills, body aches persisted for about 12 hours after onset. Headache persisted for about 24 hours after onset. Fatigue presented after the chills and body aches subsided (~24 hours after injection) and lasted about 12 hours.
About 5-10 minutes after getting DTaP, IPV, and MMR, child developed hives, nasal itching; also some hemangioma. Admitted and given Benadryl, Solumedrol, and IV fluid. Discharge summary states hoarse, agitated, tachnipnic. msv
Pt fainted after standing up after receiving imms. Fell into wall and was lowered to ground. Pt was observed in clinic and given juice/fluids. BP stabilized.
Fever, Body Aches, Headaches, Lack of Appetite, Lethargy. Managed with Ibuprofen.
Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "74-year-old male with a history of Parkinson's, dementia without behavioral disturbances, status post left nephrectomy for renal cell cancer, status post neuroendocrine tumor of the large bowel.  He presented with weakness and cough for 2-3 days duration, the wife also noted she had been sick also.  Patient found to have positive COVID testing, was admitted for workup and management.  Appears his underlying Parkinson's had worsened due to the COVID virus   Physical and occupational therapy work with him and initially were unclear about whether he would need rehab afterwards or be able to go home.  However he continued to improve and was deemed safe for discharge home.  Discussed with wife who was also ill with COVID and was unable to care for him, therapy teams had recommended 24 hour assistance and she was unable to provide this initially.  However they both continue to improve and patient was walking around the day prior to discharge with no difficulty.  Both husband and wife felt confident that today he could go home and she would be able to help care for him as his needs had decreased and she was feeling better.   Patient did not have respiratory distress during his hospital stay.  He did not require supplemental oxygen.  His main symptom was weakness and fatigue, which improved prior to discharge but was still not back at baseline   Patient with a history of orthostatic hypotension who takes Florinef for this.  He is mostly asymptomatic but did have 1 episode of dizziness when getting up going to the bathroom, orthostatic vitals done at the time were positive.  Florinef continued during hospital stay.   Patient had several episodes of hypertension during his hospital stay, he required p.r.n. labetalol.  However sometimes on repeat checks or while checking a different arm his blood pressure was in the normal range.  Most likely explanation is that his Parkinson's was causing some muscle spasms and falsely elevating his blood pressure.  He denies needing any antihypertensive medications while at home.  Will message PCP for close follow-up on this issue."
feeling weird in the head down to the chest; hot flashes; feeling of being very sick,feeling of being very sick comes in waves,feeling this ill has been debilitating; feeling this ill has been debilitating,have to lay down to rest to feel better; nausea; fatigued,really tired; at the site of the injection it got swollen like fluid got in there; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling weird in the head down to the chest), HOT FLUSH (hot flashes), MALAISE (feeling of being very sick,feeling of being very sick comes in waves,feeling this ill has been debilitating), ASTHENIA (feeling this ill has been debilitating,have to lay down to rest to feel better) and NAUSEA (nausea) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, the patient experienced FEELING ABNORMAL (feeling weird in the head down to the chest), HOT FLUSH (hot flashes), MALAISE (feeling of being very sick,feeling of being very sick comes in waves,feeling this ill has been debilitating), ASTHENIA (feeling this ill has been debilitating,have to lay down to rest to feel better), NAUSEA (nausea), FATIGUE (fatigued,really tired) and VACCINATION SITE SWELLING (at the site of the injection it got swollen like fluid got in there). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 15-Jul-2021, VACCINATION SITE SWELLING (at the site of the injection it got swollen like fluid got in there) had resolved. At the time of the report, FEELING ABNORMAL (feeling weird in the head down to the chest), HOT FLUSH (hot flashes), MALAISE (feeling of being very sick,feeling of being very sick comes in waves,feeling this ill has been debilitating), ASTHENIA (feeling this ill has been debilitating,have to lay down to rest to feel better), NAUSEA (nausea) and FATIGUE (fatigued,really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications included lot of supplements and most of them help with the patients prostate. The patient explained this feeling of being very sick comes in waves now. Sometimes the patient thinks they maybe feeling better and then it comes back and they have to lay down to rest to feel better. The patient has not gone back to get the second dose because they have been feeling so ill still and they would like to wait until they feel better.
Approximately 7-10 days after the vaccine patient reported weakness and loss of strength in her hands, she was hardly able to walk in her right leg and left leg pain. These issues have still continued through today
12/21/19 - Seizure lasting > 7 minutes. Has Seizure Disorder Last Seizure 5/2019. On Keppra 700 mg BID & No missed doses per caretaker. Keppra level < 2.5Mg/ml (10-40 range) Treated with IV Keppra & sent home with increase Keppra dose to 750mg BID
after receiving vaccine patient stood up walked out of immunization room, stood momentarily at drop off counter and fainted
5 month old male, previously healthy, developed fever 103 15 hours after vax. "Mosquito bit" redness at thigh.  Given Tylenol, fever decreased to 99 degrees, moving leg normally, eating well, redness to thigh improved- stable.
Approximately 8 to 10 minutes after administration of adult dT and PPD 5 TU, patient became dizzy standing while leaving office, fell and hit head on way down and then had a very brief generalized seizure.
This case was reported in a literature article and described the occurrence of systemic lupus erythematosis flare in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine unspecified (manufacturer unspecified). Subject's medical condition included systemic lupus erythematosus. On an unspecified date, the subject received an unspecified dose of influenza vaccine unspecified (unknown route and injection site, batch number not provided). 12 weeks after vaccination with influenza vaccine unspecified, the subject experienced systemic lupus erythematosis flare (SELENA-SLEDAI defined disease flare). Plasma samples were obtained from the subject on the day of influenza vaccination and at 12 weeks post vaccination. Plasma samples were tested for 52 soluble inflammatory mediators using xMAP technology. TNFR family members, TNFRI, TNFRII, Fas, FasL, CD40L, were increased. This case was assessed as medically serious by GSK. At the time of reporting, the outcome of the event was unspecified. Summary of the article: This literature article referred to 28 systemic lupus erythematosus (SLE) patients (age and gender not specified) who exhibited SELENA-SLEDAI defined disease flare after 6 (n=13) or 12 (n=15) weeks post influenza vaccination (manufacturer, dosage and injection sites unknown) on an unspecified date. Subjects' medical history and concomitant medications at the time of the event were unknown. Twenty-eight SLE patients exhibited SELENA-SLEDAI defined disease flare after 6 (n=13) or 12 (n=15) weeks post influenza vaccination (manufacturer, dosage and injection sites unknown) on an unspecified date. These 28 patients were part of a study conducted to understand mechanisms and identify biomarkers of flare to help prevent damage and improvement management. Plasma samples were obtained from SLE patients on the day of influenza vaccination (BL) and at 6 and 12 weeks post (FU). Each SLE patient was matched to a unique SLE patient who did not flare (NF), and to a healthy control (HC). Samples from 13 SLE patients with flare were compared to samples from a non-flare year (self nonflare, SNF). Plasma samples were tested for 52 soluble inflammatory mediators, using xMAP technology. SLE patients who exhibited disease flare and significantly (p < 0.01) higher levels of BL pro-inflammatory mediators, including Th1, Th2, and Th17-type cytokines compared to NF/SNF SLE patients and HC. Regulatory cytokines, including IL-10 and TGF-Beta were increased (p < 0.01) at BL in SLE patients not exhibiting disease flare (NF/SNF) compared to SLE flare and HC. TNFR family members, TNFRI, TNFRII, Fas, FasL, CD40L, were increased at BL in SLE flare patients. Select serum cytokines and chemokines are elevated in patients before SLE disease flare, providing important pathways to dissect for mechanism of flare, therapeutic selection or development.
Around 1 am on 1/29/2021, hot flashes, fever 99, & a little bit nauseas this lasted 48hrs. My legs felt weak & shaky legs and fuzzy head. I feel with no energy. This symptoms are still going on.
Chronic headaches; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and HEADACHE (Chronic headaches) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VERTIGO (Vertigo). On an unknown date, the patient experienced HEADACHE (Chronic headaches). The patient was treated with MECLIZINE HCL for Vertigo, at a dose of 1 dosage form. At the time of the report, VERTIGO (Vertigo) and HEADACHE (Chronic headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Event added.
pt recv vax 8JUN04 & 20JUN94 pt devel a fever of 101.4 generalized measle-like rash, irritability; pt recovered on 27JUN94;
Gave patient Prevnar 13 vaccine in upper right deltoid. After immunization, patient developed a small bump at the injection site. Patient exprienced no pain or redness at the site and felt fine. Monitored patient after vaccination, no pain or breathing issues. Counseled patient that a small bump can occur at the injection site and to put some ice on the arm to bring down any swelling. Could also take a tablet of benadryl to bring down the reaction. Had a second pharmacist, look at the reaction and agreed it was a localized reaction. Called patient back in the evening and she was having no other issues.
PAIN ALL OVER BODY, FROM ANKLES UP TO HEAD (WORST BACK, CHEST NOT GOOD); SLEEPLESSNESS; FEELING LIKE DYING, NOT MAKING IT; SHORTNESS OF BREATH; NOT EATEN ANYTHING IN DAYS; This spontaneous report received from a patient concerned a 69 year old male. The patient's height, and weight were not reported. The patient's past medical history included horrible accident, right femur replaced, both ankles replaced, both knees replaced, and fuse lower back, and concurrent conditions included artificial hip, blurry vision, ptds (post traumatic demoralization syndrome), and panic attacks. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAY-2021, the subject experienced pain all over body, from ankles up to head (worst back, chest not good). On MAY-2021, the subject experienced sleeplessness. On MAY-2021, the subject experienced feeling like dying, not making it. On MAY-2021, the subject experienced shortness of breath. On MAY-2021, the subject experienced not eaten anything in days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain all over body, from ankles up to head (worst back, chest not good), and the outcome of sleeplessness, feeling like dying, not making it, shortness of breath and not eaten anything in days was not reported. This report was non-serious.